Filing Details
- Accession Number:
- 0001022079-16-000314
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-08-11 16:32:05
- Reporting Period:
- 2016-08-10
- Filing Date:
- 2016-08-11
- Accepted Time:
- 2016-08-11 16:32:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1022079 | Quest Diagnostics Inc | DGX | Services-Medical Laboratories (8071) | 161387862 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1142318 | K Jenne Britell | C/O Quest Diagnostics 3 Giralda Farms Madison NJ 07940 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-08-10 | 4,000 | $55.76 | 23,876 | No | 4 | M | Indirect | by Trust |
| Common Stock | Disposition | 2016-08-10 | 4,000 | $85.20 | 19,885 | No | 4 | S | Indirect | by Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Indirect | by Trust |
| No | 4 | S | Indirect | by Trust |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to Buy) | Disposition | 2016-08-10 | 4,000 | $55.76 | 4,000 | $55.76 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 4,000 | 2020-05-06 | No | 4 | M | Indirect |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $85.19 to $85.22. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors.
- The options vested in three annual installments beginning with the first on May 6, 2011, the second on May 6, 2012 and the final on May 6, 2013.
Billionaire Hedge Funds
